Literature DB >> 8085133

Age at onset in subtypes of schizophrenic disorders.

S Beratis1, J Gabriel, S Hoidas.   

Abstract

Age at onset and sex differences in the age at onset were investigated in the schizophrenic subtypes of 200 patients. Significant differences in the age at onset were observed among these subtypes; the disorganized subtype demonstrated the earliest and the paranoid the latest onset. The mean age at onset of all female patients was significantly greater than that of the male. Specifically, in the paranoid subtype the onset for men occurred earlier than for women. Conversely, in the disorganized subtype the disorder appeared earlier in women. There was no significant sex difference in the age at onset in the undifferentiated and the residual subtypes. In the paranoid subtype most men developed the disease before age 30 (72%), whereas women had an even distribution of the onset before and after 30. Ninety-six patients admitted for the first time demonstrated findings similar to those of the total sample. The data provide additional information on the phenotypic expression of the subtypes of schizophrenic disorders and indicate the necessity for further demographic and genetic studies to delineate the underlying defect.

Entities:  

Mesh:

Year:  1994        PMID: 8085133     DOI: 10.1093/schbul/20.2.287

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  16 in total

Review 1.  Adolescent schizophrenia: a methodologic review of the current neuroimaging and neuropsychologic literature.

Authors:  R L Findling; L Friedman; J T Kenny; T P Swales; D M Cola; S C Schulz
Journal:  J Autism Dev Disord       Date:  1995-12

2.  Ziprasidone in adolescents with schizophrenia: results from a placebo-controlled efficacy and long-term open-extension study.

Authors:  Robert L Findling; Idil Cavuş; Elizabeth Pappadopulos; Douglas G Vanderburg; Jeffrey H Schwartz; Balarama K Gundapaneni; Melissa P DelBello
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-10-10       Impact factor: 2.576

Review 3.  Olanzapine: in adolescents with schizophrenia or bipolar I disorder.

Authors:  Paul L McCormack
Journal:  CNS Drugs       Date:  2010-05       Impact factor: 5.749

Review 4.  Stem cell-based models and therapies: a key approach into schizophrenia treatment.

Authors:  Bagher Larijani; Peyvand Parhizkar Roudsari; Mahdieh Hadavandkhani; Sepideh Alavi-Moghadam; Mostafa Rezaei-Tavirani; Parisa Goodarzi; Forough Azam Sayahpour; Fereshteh Mohamadi-Jahani; Babak Arjmand
Journal:  Cell Tissue Bank       Date:  2021-01-02       Impact factor: 1.522

5.  The role of estrogen and testosterone in female rats in behavioral models of relevance to schizophrenia.

Authors:  Andrea Gogos; Perrin Kwek; Maarten van den Buuse
Journal:  Psychopharmacology (Berl)       Date:  2011-07-29       Impact factor: 4.530

6.  Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia.

Authors:  Robert L Findling; Ronald P Landbloom; Mary Mackle; Wendi Pallozzi; Sabine Braat; Carla Hundt; Marianne Z Wamboldt; Maju Mathews
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-06       Impact factor: 2.576

7.  Grey matter, an endophenotype for schizophrenia? A voxel-based morphometry study in siblings of patients with schizophrenia.

Authors:  Jorien van der Velde; Paula M Gromann; Marte Swart; Lieuwe de Haan; Durk Wiersma; Richard Bruggeman; Lydia Krabbendam; André Aleman
Journal:  J Psychiatry Neurosci       Date:  2015-05       Impact factor: 6.186

8.  Treatment of the special patient with schizophrenia.

Authors:  R R Conley; D L Kelly
Journal:  Dialogues Clin Neurosci       Date:  2001-06       Impact factor: 5.986

9.  Variability of ecological executive function in children and adolescents genetically at high risk for schizophrenia: a latent class analysis.

Authors:  Meng Li; Yang Li; Jiwei Sun; Di Shao; Qianqian Yang; Fenglin Cao
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-05-25       Impact factor: 5.349

10.  Testosterone regulation of sex steroid-related mRNAs and dopamine-related mRNAs in adolescent male rat substantia nigra.

Authors:  Tertia D Purves-Tyson; David J Handelsman; Kay L Double; Samantha J Owens; Sonia Bustamante; Cynthia Shannon Weickert
Journal:  BMC Neurosci       Date:  2012-08-06       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.